EDESA BIOTECH, INC. Goodwill, Foreign Currency Translation Gain (Loss)
EDESA BIOTECH, INC. (EDSA) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$25.07 thousand for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-10.
Discontinued › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2023-02-10
- EDESA BIOTECH, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2022-12-31 was -$25.07K, a 178.71% decline year-over-year.
- EDESA BIOTECH, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2021-12-31 was $31.85K.
- EDESA BIOTECH, INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$8.34K, a 110.18% decline from fiscal 2021.
- EDESA BIOTECH, INC. goodwill, foreign currency translation gain (loss) for fiscal 2021 was $81.94K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|
| 2022-12-31 | -$25.07K 10-Q · filed 2023-02-10 | |
| 2022-09-30 | -$8.34K 10-K · filed 2022-12-16 | |
| 2021-12-31 | $31.85K 10-Q · filed 2023-02-10 | |
| 2021-09-30 | $81.94K 10-K · filed 2022-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |